exception of an elevated erythrocyte sedimentation rate of 35 mm/hour (normal 0-15 mm/hour). Cerebrospinal fluid analysis revealed normal glucose and protein levels and 17 white blood cells (100% mononuclear cells) with sterile cultures. A magnetic resonance (MR) image of the thoracic spine revealed an enhancing intramedullary lesion at T4-5, which we believed might be an intramedullary tumor (Fig. 1) .
Operation. A T4-6 laminectomy was performed and the lesion was identified using intraoperative ultrasonography. On opening the dura, the spinal cord was mildly expanded but otherwise normal in appearance. A midline myelotomy was performed and a reddish-gray mass was encountered. The lesion was relatively well circumscribed and was easily dissected from the interior of the spinal cord.
Histological Examination. Microscopic examination of the lesion revealed a lymphohistiocytic infiltrate with plasma cells scattered throughout (Fig. 2) . The histiocytes stained positive for S-100 protein. Of note was the absence of macrophages and eosinophils. Stains for acidfast bacilli and fungi were negative. The findings were believed to be consistent with a diagnosis of extranodal Rosai-Dorfman disease.
Postoperative Course. The patient had an uncomplicated postoperative course. He underwent an evaluation that included computerized tomography of the chest, abdomen, and pelvis, as well as a bone scan designed to locate extranodal sites of disease, but none was identified. No indication for adjunctive radiation and/or chemotherapy was observed at the time. The patient was discharged to a spinal cord rehabilitation unit and over the next 6 months he regained antigravity strength in his distal lower extremities. As of his 1-year follow-up review, he has slightly better than antigravity strength in the distal lower extremities but is still unable to walk due to residual proximal weakness. A follow-up MR image shows residual abnormal signal within the cord but no discrete lesion.
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Discussion
Rosai and Dorfman 18 originally described SHML in 1969. Following the original description, a registry of patients harboring this unusual condition was established for reporting and collating new cases. 7 A rare histiocytic lymphoproliferative disorder, SHML has been classified as an idiopathic histiocytosis. The cause of the disorder is unknown. Because of its tendency to form large masses, some pathologists have suggested that SHML represents a neoplastic process. 7 On the other hand, the high incidence of immunological abnormalities in patients with SHML has led some researchers to consider SHML to be an immunological disturbance. 7, 13 Others have even proposed an infectious etiology based on the presence of elevated titers of antibodies to the Epstein-Barr virus in some individuals. 7 However, lacking compelling evidence as to a clear etiology, the morphological and clinical overlap between SHML and the prototypical histiocytosis (that is, Langerhan's cell histiocytosis) provides good reason to classify SHML with histiocytoses.
Sinus histiocytosis with massive lymphadenopathy typically affects otherwise healthy Caucasian or AfricanAmerican males. The average age of the patient at onset is approximately 20 years of age, although the disease has been reported to occur at the extreme ends of the age range. The typical clinical presentation is painless bilateral cervical lymphadenopathy, which is seen in nearly 90% of patients. 7, 8, 19 Axillary, inguinal, and mediastinal nodes are also affected although less frequently than cervical nodes. Fever and weight loss are not uncommon parts of the clinical picture. Laboratory findings are generally nonspecific. The erythrocyte sedimentation rate is elevated in 90% of cases and a mild anemia (normochromic, normocytic, or hypochromic microcytic) is not uncommon. The peripheral white blood cell count is usually normal. Most patients have abnormalities in their serum protein levels consisting of elevation of the gamma globulin fraction; however, a monoclonal gammopathy is rare. 7 Other seroimmunological markers, such as rheumatoid factor and antinuclear antibody, may be inconsistently positive, although the significance of this is unclear. Extranodal sites of SHML occur in 43% of patients. Indeed, generally it has been the extranodal sites of disease that have drawn the most attention in the literature. The most common sites of extranodal disease include the orbit, skin, soft tissues, paranasal sinuses, upper respiratory tract, and bone. 1, 8, 9, 14, 16, 17 Multiple extranodal sites can be seen in the same patient. Central nervous system involvement in SHML is unusual; there have been only 23 cases with involvement of the nervous system reported (Table 1) . Ironically, 50% of patients with CNS involvement do not have nodal disease; however, it is distinctly rare to have isolated CNS involvement without evidence of either nodal disease or other sites of extranodal involvement.
Central nervous system involvement by SHML usually presents with involvement of the skull and/or intracranial compartment approximately twice as frequently as it does in the spine. 8 Including this case, there have been only nine cases of SHML reported that involved the spine and/or intraspinal structures. Most often, the disease is confined to the epidural space; only two cases have been reported with subdural disease and our case represents the only reported case of SHML involving the spinal cord parenchyma.
The differential diagnosis in this case was mainly that of a primary intramedullary spinal cord tumor. Other more unusual possibilities considered less likely included metastatic carcinoma, lymphoma, leukemia, and sarcoma. However, in the absence of systemic illness, which may accompany entities such as lymphoma, leukemia, and so forth, these lesions are indistinguishable clinically and there are no pathognomonic radiographic hallmarks to suggest a particular preoperative diagnosis. In the typical case of SHML, histological examination with hematoxylin and eosin reveals expansion of the lymph node sinus by numerous histiocytes with abundant pale pink cytoplasm. The cytoplasm of many of the histiocytes may contain well-preserved lymphocytes, a phenomenon referred to as lymphophagocytosis. The nuclei are usually large with prominent nucleoli and although nuclear atypia may sometimes be seen, significant mitotic activity within the histiocytes is relatively uncommon. Nonetheless, occasional mitotic figures may be seen in otherwise typical cases. The histiocytes stain strongly for S-100 protein.
Histologically, SHML must be differentiated from a number of other pathological entities that may resemble SHML. These include metastatic melanoma or carcinoma, Hodgkin's disease, malignant histiocytosis, histiocytic lymphoma, and histiocytosis X, as well as a variety of infectious diseases. 3, 8 Our case illustrates several noteworthy characteristics. The patient was older than the typical patient presenting with SHML and, aside from a moderately elevated erythrocyte sedimentation rate, other clinical features characteristic of the disease were absent. The disease was confined to the spinal cord with no evidence of nodal disease or other sites of extranodal involvement. To our knowledge, this case represents the only one of its kind.
The natural history of SHML is difficult to predict. Earlier reports emphasized an illness typically lasting months to years but customarily resulting in complete remission and recovery. More recent information has deemphasized the tendency for SHML to undergo complete remission. 18, 19 Although patients with SHML do experience complete remission of disease, as many as two-thirds of individuals may have clinical or pathological evidence of persistent yet stable disease. 8 Clearly, it is uncommon for SHML to be progressive and death as a direct result of SHML is rare. In terms of CNS disease, morbidity related to SHML is more likely to be related to the site of involvement than the pathological entity of SHML.
There has been no systematic study regarding the treatment of SHML. Indeed, treatment may be unnecessary in many cases because SHML usually does not threaten life or organ function. Treatment modalities that have been reported include surgery, chemotherapy, corticosteroid medications, and radiation therapy. 12 Surgical intervention has consisted for the most part of either incisional or excisional biopsy for the purpose of diagnosis, although major surgical procedures have been performed. 1,2,4,13,20-22 A variety of chemotherapy regimens have been used either as single agents or in combination. The review by Komp 12 revealed a statistically significant benefit associated with the use of combination chemotherapy as opposed to a single agent, the most effective combination being an alkylating agent combined with a vinca alkaloid and corticosteroid medications. It should be noted, however, that response rates were found to be markedly inferior to those seen in other hematopoietic diseases such as lymphoma and leukemia. Radiation therapy has also been used as adjunctive therapy in SHML. Komp 12 identified 34 patients who received radiation as part of their treatment. Less than one-third (10 of 34) of these patients had even a partial response to radiation. Similar to chemotherapy response rates, the response at higher radiation doses was again inferior to that expected with hematological malignancies. In general, the primary indications for radiation have been treatment of respiratory compromise due to airway obstruction and treatment of spinal cord compression due to either epidural or subdural disease. In our case, surgical intervention was believed to be indicated for diagnosis and attempted resection of the mass, which was accomplished. Because a gross-total resection of the lesion was achieved, there was believed to be no indication for either chemotherapy or radiation treatment. Because there does not appear to be any definitive treatment for SHML, the purpose of therapy should be control of local disease when it threatens function. In this regard, surgery would seem to be the most effective treatment modality.
